Increase in vasopressin binding sites in the human choroid plexus in Alzheimer's disease

Brain Research

Volumn 706, Issue 1, 1996, Pages 151-154

  Korting, C ^a   Van Zwieten, E J ^a   Boer, G J ^a   Ravid, R ^a   Swaab, D F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Human brain; Linear V(1a) antagonist choroid plexus; Vasopressin binding sites

Indexed keywords

VASOPRESSIN RECEPTOR;

ADULT; AGED; ARTICLE; CHOROID PLEXUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0030031979     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01242-7     Document Type: Article

References (33)

1. Brownfield, M.S. and Kozlowski, G.P., The hypothalamochoroidal tract. I. Immunohistochemical demonstration of neurophysin pathways to telencephalic choroid plexuses and cerebrospinal fluid. Cell. Tiss. Res., 178 (1977) 111-127.
2. Buijs, R.M., De Vries, G.J., Van Leeuwen, F.W. and Swaab, D.F., The Neurohypophysis: Structure, Function and Control. In B.A. Cross and G. Leng (Eds.), Progress in Brain Research, Vol 60, Elsevier, Amsterdam, 1983, pp. 115-122.
3. Caffé, A.R., Van Leeuwen, F.W. and Luiten, P.G.M., Vasopressin cells in the medial amygdala project to the lateral septum and the ventral hippocampus, J. Comp. Neurol., 261 (1987) 237-252.
4. Caffé, A.R., Van Ryen, P.C. and Van Leeuwen, F.W., Vasopressin and oxytocin systems in the brain and upper spinal cord of Macaca fascicularis, J. Comp. Neurol., 287 (1989) 302-325.
5. Cunningham, E.T. and Sawchenko, P.E., Reflex control of magnocellular zasopressin and oxytocin secretion. Trends Neurosci., 14 (1991) 406-411.
6. De Vries, G.J., Buijs, R.M., Van Leeuwen, F.W., Caffé, A.R. and Swaab, D.F., The vasopressinergic innervation of the brain in normal and castrated rats, J. Comp. Neurol., 233 (1985) 236-254.
7. Faraci, F.M., Mayhan, W.G., Farrell, W.J. and Heistad, D.D., Humoral regulation of blood flow to choroid plexus: role of arginine vasopressin, Circ. Res., 63 (1988) 373-379.
8. Faraci, F.M., Mayhan, W.G. and Heistad, D.D., Effect of vasopressin on production of cerebrospinal fluid: possible role of vasopressin (V1)-receptors, Am. J. Physiol., 27 (1990) R94-R98.
9. Fliers, E., Guldenaar, S.E.F. and Swaab, D.F., Extrahypothalamic vasopressin and oxytocin in the human brain: presence of vasopressin cells in the bed nucleus of the stria terminalis. Brain Res., 375 (1986) 363-367.
10. Johnson, A.E., Audigier, S., Rossi, F., Jard, S., Tribollet, E. and Barberis, C., Localization and characterization of vasopressin binding sites in the rat brain using an iodinated lineair AVP antagonist, Brain Res., 622 (1993) 9-16.
11. Jolkkonen, J., Helkala, E.L., Kutvonen, R., Lehtinen, M. and Riekkinen, P.J., Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance, Psychoneuroendocrinology, 14 (1989) 89-95.
12. Maktabi, M.A., Elbokl, F.F., Faraci, F.M. and Todd, M.M., Halothane decreases the rate of production of cerebrospinal fluid. Possible role of vasopressin V1 receptors, Anesthesiology, 78 (1993) 72-82.
13. Markwell, M.A., Haas, S.M., Bieber, L.L. and Tolbert, N.E., A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples, Anal. Biochem., 87 (1978) 206-210.
14. May, C., Kaye, J.A., Atack, J.R., Schapiro, M.B., Friedland, R.P. and Rapoport, S.I., Cerebrospinal fluid production is reduced in healthy aging, Neurology, 40 (1990) 500-503.
15. Mazurek, M.F., Growdon, J.H., Beal, M.F. and Martin, J.B., CSF vasopressin concentration is reduced in Alzheimer's disease, Neurology, 36 (1986) 1133-1137.
16. McKhann, G., Drachmann, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of health and human services task force on Alzheimer's disease, Neurology, 34 (1984) 939-944.
17. Murphy, D.G., DeCarli, C., Schapiro, M.B., Rapoport, S.I. and Horwitz, B., Age-related differences in volumes of subcortical nuclei, brain matter, and cerebrospinal fluid in healthy men as measured with magnetic resonance imaging [published erratum appeared in Arch Neurol 1994 Jan; 51(0):60], Arch. Neurol., 49 (1992) 839-845.
18. Murphy, D.G., DeCarli, C.D., Daly, E., Gillette, J.A., McIntosh, A.R., Haxby, J.V., Schapiro, M.B., Rapoport, S.I. and Horwitz, B., Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: correlations with disease severity, Biol. Psychiatry, 34 (1993) 612-621.
19. Nilsson, C., Lindvall-Axelsson, M. and Owman, C., Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system, Brain Res. Rev., 17 (1992) 109-138.
20. North, W.G., Harbaugh, R. and Reeder, T., An evaluation of human neurophysin production in Alzheimer's disease: preliminary observations. Neurobiol. Aging, 13 (1992) 261-265.
21. Raskind, M.A., Peskind, E.R., Lampe, T.H., Risse, S.C., Taborsky, G.J. and Dorsa, D., Cerebrospinal fluid vasopressin, oxytocin, somatostatin, and B-endorphin in Alzheimer's disease, Arch. Gen. Psychiatry, 43 (1986) 382-388.
22. Reisberg, B., Ferris, S.H., Kluger, A., Franssen, E., De Leon, M.J., Mittelman, M., Borenstein, J., Rameshwar, K. and Alba, R., Symptomatic changes in CNS aging and dementia of the Alzheimer type: cross-sectional, temporal and remediable concomitants. In Bergener and Reisberg (Eds.), Diagnosis and Treatment of Senile Dementia, Springer-Verlag, Berlin, 1989.
23. Rodbard, D., Lessons from the computerization of radioimmunoassays: an introduction to basic principles of modelling. In Rodbard and Forti (Eds.), Computers in Endocrinology, Raven Press, New York, 1984.
24. Schmidt, A., Audigier, S., Barberis, C., Jard, S., Manning, M., Kolodziejczyk, A.S. and Sawyer, W.H., A radioiodinated linear vasopressin antagonist: a ligand with high affinity and specificity for V1a receptors, FEBS Lett., 282 (1991) 77-81.
25. Sørensen, P.E., Gjerris, A. and Hammer, M., Cerebrospinal fluid vasopressin in neurological and psychiatric disorders, J. Neurol. Neurosurg. Psychol., 48 (1985) 50-57.
26. Swaab, D.F., Fliers, E. and Partiman, T.S., The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res., 342 (1985) 37-44.
27. Swaab, D.F., Hofman, M.A., Lucassen, P.J., Purba, J.S., Raadsheer, F.C. and Van de Nes, J.A.P., Functional neuroanatomy and neuropathology of the human hypothalamus, Anal. Embryol., 187 (1993) 317-330.
28. Tribollet, E., Barberis, C., Jard, S., Duhois-Dauphin, M. and Dreifuss, J.J., Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography, Brain Res., 442 (1988) 105-118.
29. Tsuji, M., Takahashi, S. and Akazawa, S., CSF vasopressin and cyclic nucleotide concentrations in senile dementia, Psychoneuroendocrinology, 6 (1981) 171-176.
30. Van Leeuwen, F.W., Van der Beek, E.M., Van Heerikhuize, J.J., Wolters, P., Van der Meulen, G. and Yieh-Ping, W., Quantitative light microscopic autoradiographic localization of binding sites labelled with (3H)vasopressin antagonist d(CH2)5Tyr(Me)VP in the rat brain, pituitary and kidney, Neurosci. Lett., 80 (1987) 121-126.
31. Van Zwieten, E.J., Ravid, R., Swaab, D.F. and Van de Woude, T., Immunocytochemically stained vasopressin binding sites on blood vessels in the rat brain, Brain Res., 474 (1988) 369-373.
32. Van Zwieten, E.J., Van Heerikhuize, J.J., Pool, C.W., Ravid, R. and Swaab, D.F., Vasopressin binding sites in the aging rat brain: a quantitative autoradiographic study using an iodinated linear vasopressin antagonist, Neurobiol. Aging, (1995).
33. Wahlund, L.O., Andersson-Lundman, G., Basun, H., Almkvist, O., Bjorksten, K.S. and Wetterberg, L., Cognitive functions and brain structures: a quantitative study of CSF volumes on Alzheimer patients and healthy control subjects, Magn. Reson. Imaging, 11 (1993) 169-174.